BT5K season is here! Join the community and walk or run to make strides against brain tumors!
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
After losing her husband to GBM in 2022 and receiving her own diagnosis, survivor Beth Kassab didn’t know what to expect attending the largest brain tumor conference in Chicago. Read Beth’s top takeaways:
Discover how one couple’s efforts to make a difference after their young son was diagnosed with a brain tumor led to their vital role in establishing the ABTA and ensuring its ongoing success.
After losing her daughter Kristi to GBM in 2011, Sally set out to carry on her daughter’s legacy of living life to the fullest and supporting brain tumor research.
The ABTA is proud to announce eight recipients of the Medical Student Summer Fellowship grants.
You can make a difference and raise critical funds for research by joining a Breakthrough for Brain Tumors 5k Run & Walk event.
Join us July 19 to raise $50K for GBM research.
With the reigniting of the White House’s Cancer Moonshot Initiative, the ABTA recently joined the Brain Cancers Forum in Washington, D.C., to discuss opportunities in discovering treatments for brain cancers, including GBM.
A first-in-class targeted therapy for low-grade glioma could gain FDA approval as early as spring 2024. Here are three things you should know about the emerging drug “vorasidenib.”
Always free for patients & caregivers
This spring, your gift will be matched dollar for dollar thanks to the generosity of two anonymous donors!
